Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 7Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 6Observational 1

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 2

Conditions

Breast Neoplasms 1223Neoplasms 1041Carcinoma, Non-Small-Cell Lung 755Prostatic Neoplasms 693Colorectal Neoplasms 593Lung Neoplasms 574Pancreatic Neoplasms 402Leukemia, Myeloid, Acute 399Neoplasm Metastasis 387Multiple Myeloma 374Ovarian Neoplasms 372Stomach Neoplasms 317Carcinoma, Hepatocellular 303Melanoma 282Recurrence 281Brain Neoplasms 281Squamous Cell Carcinoma of Head and Neck 268Head and Neck Neoplasms 237Endometrial Neoplasms 235Glioblastoma 234Triple Negative Breast Neoplasms 230Precursor Cell Lymphoblastic Leukemia-Lymphoma 226Uterine Cervical Neoplasms 225Lymphoma 224Hematologic Neoplasms 200Sarcoma 199Urinary Bladder Neoplasms 197Esophageal Neoplasms 191Carcinoma, Renal Cell 190Lymphoma, Non-Hodgkin 176

Interventions

Mitomycin 2tislelizumab 1molgramostim 1cryoprecipitate coagulum 1Standard of Care 1Hyperthermic Intraperitoneal Chemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × Pseudomyxoma Peritonei × 1 year × Clear all
NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

University of Kentucky

Phase 2 Recruiting
100 enrolled
GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT06617897 2026-03-11

Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery

CSL Behring

Phase 3 Recruiting
90 enrolled

Afibrinogenemia, Blood Coagulation Disorders, Pseudomyxoma Peritonei

NCT07451483 2026-03-05

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Jules Bordet Institute

Recruiting
500 enrolled
GastrointestinalGynecologic

Hernia, Ventral, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT06513065 2026-02-19

HIPEC-PMP

University of Southampton

Phase 3 Recruiting
176 enrolled

Pseudomyxoma Peritonei

NCT04024917 2026-01-16

COCOON

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Recruiting
60 enrolled
Gynecologic

Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT07341360 2026-01-14

Pseudovax

Oslo University Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled

Pseudomyxoma Peritonei

NCT07328737 2026-01-09

One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei

Beijing Tsinghua Chang Gung Hospital

Phase NA Recruiting
132 enrolled

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon âš¡